Tim McCarthy McCarthy
Chief Executive Officer at IMMUPHARMA PLC
Net worth: 745 008 $ as of 2024-03-30
Profile
Timothy Paul McCarthy is the founder of Alizyme Plc, which was founded in 1995.
He served as the Chief Executive Officer & Finance Director from 1995 to 2009.
Mr. McCarthy's current job(s) include being the Chairman & Chief Executive Officer at ImmuPharma Plc since 2015.
He is also the Chairman at Incanthera Research & Development Ltd., ARK Analytics Solutions Ltd., and Incanthera Plc since their respective job starts.
Additionally, he is the Independent Non-Executive Chairman at 4basebio Plc since 2020.
He holds the position of Director at Spear Therapeutics Ltd., Executive Director at Unnamed Ltd., and Director at Frangipani Dreams Ltd.
He is also a Director at Incanthera Therapeutics Ltd.
and Incanthera R&D Ltd.
since 2014.
Furthermore, he is a Member of the Association of Chartered Certified Accountants.
Mr. McCarthy's former jobs include being the Chief Executive Officer & Finance Director at Acambis Plc.
He also served as the Chairman at Harvard Healthcare Ltd.
and Dropped Ltd.
He was a Director at Expedeon Ltd.
from 2006 to 2009 and a Director at Expedeon Holdings Ltd.
He was also a Director at Wise Old Owl Ltd.
Additionally, he was a Member-Supervisory Board at 2invest AG from 2016 to 2020.
Mr. McCarthy's education includes an MBA from Cranfield School of Management.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
Incanthera Plc
4.27% | 2022-08-17 | 3,931,646 ( 4.27% ) | 745 008 $ | 2024-03-30 |
Tim McCarthy McCarthy active positions
| Companies | Position | Start |
|---|---|---|
| IMMUPHARMA PLC | Chief Executive Officer | 2021-07-29 |
| 4BASEBIO PLC | Chairman | 2020-12-21 |
| Unnamed Ltd. | Director/Board Member | - |
| Incanthera R&D Ltd. | Director/Board Member | - |
| Incanthera Therapeutics Ltd. | Director/Board Member | 2014-12-13 |
| Incanthera Plc | Chairman | 2017-10-22 |
| Frangipani Dreams Ltd. | Director/Board Member | - |
| ARK Analytics Solutions Ltd. | Chairman | - |
Spear Therapeutics Ltd.
 Spear Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Spear Therapeutics Ltd. develops cancer treatment drugs. The firm offers cytochrome P450 (CYP)-activated prodrugs. It designs prodrugs that are activated by enzymes that are found in cancer tissues. The company was founded by Steven A. Everett and Gerard Andrew Potter and is headquartered in Manchester, the United Kingdom. | Director/Board Member | 2014-12-11 |
| ░░░░░░░░░░ ░░░░░░░░ ░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | - |
Former positions of Tim McCarthy McCarthy
| Companies | Position | End |
|---|---|---|
| ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Training of Tim McCarthy McCarthy
| Cranfield School of Management | Masters Business Admin |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| 2INVEST AG | Finance |
| IMMUPHARMA PLC | Health Technology |
| 4BASEBIO PLC | Health Technology |
| Private companies | 16 |
|---|---|
Acambis Plc
 Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Health Technology |
Alizyme Plc
 Alizyme Plc Pharmaceuticals: MajorHealth Technology Alizyme Plc was engaged in the development of pharmaceutical products for the diseases related to obesity treatment. The company was founded in 1995 and was headquartered in Cambridge, the United Kingdom. | Health Technology |
Association of Chartered Certified Accountants
 Association of Chartered Certified Accountants Miscellaneous Commercial ServicesCommercial Services The Association of Chartered Certified Accountants (ACCA) is a professional body for accountants. The non-profit company is based in Glasgow, UK, and has subsidiaries in Mauritius, United Kingdom, and Hong Kong. The British company offers a program called ALP-C, which approves learning materials from high-quality content providers to support studying towards ACCA's qualification. The role of the CFO is evolving beyond finance to include reporting on value-centric aspects of their operations, as companies move towards sustainable practices. The CEO of the company is Helen Joanna Brand. | Commercial Services |
Expedeon Ltd.
 Expedeon Ltd. BiotechnologyHealth Technology Expedeon Ltd. develops and produces proteins for drug discovery. Its products include gel electrophoresis, nucleic acid kits, protein quantitation, western blotting reagents and spectroscopy. The firm provides genomics and proteomics tools to scientists. The company was founded by Heikki Lanckriet in 2003 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Spear Therapeutics Ltd.
Spear Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Spear Therapeutics Ltd. develops cancer treatment drugs. The firm offers cytochrome P450 (CYP)-activated prodrugs. It designs prodrugs that are activated by enzymes that are found in cancer tissues. The company was founded by Steven A. Everett and Gerard Andrew Potter and is headquartered in Manchester, the United Kingdom. | Health Technology |
Expedeon Holdings Ltd.
 Expedeon Holdings Ltd. BiotechnologyHealth Technology Expedeon Holdings Ltd. develops, manufactures, and commercializes proteomics reagents and tools. The company was founded on January 7, 2009 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Incanthera Research & Development Ltd.
 Incanthera Research & Development Ltd. Medical DistributorsDistribution Services Incanthera Research & Development Ltd. develops drug delivery solutions for solid tumor chemotherapy. It offers cancer therapies, such as ICT01-2588, a vascular disrupting agent and drug delivery platform for lung and prostate cancer; and ICT03-Es5, a bioreductive anticancer agent for lung, liver, and breast cancer. The company was founded by Alan McGowan, Paul Loadman, Laurence Patterson, Andrew John Michael Duley, John Anthony Hadfield, Robert Falconer, and Jason Gill in 2010 and is headquartered in Manchester, the United Kingdom. | Distribution Services |
| Harvard Healthcare Ltd. | Health Technology |
| Unnamed Ltd. | |
| ARK Analytics Solutions Ltd. | |
| Dropped Ltd. | |
| Wise Old Owl Ltd. | |
| Frangipani Dreams Ltd. | |
| Incanthera Plc | |
| Incanthera Therapeutics Ltd. | |
| Incanthera R&D Ltd. |
- Stock Market
- Insiders
- Tim McCarthy McCarthy
